Kenneth Kolinsky
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
Papers in
- Oncology 24
- Cancer-related Molecular Pathways 8
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 6
-
- Melanoma and MAPK Pathways 7
- Angiogenesis and VEGF in Cancer 6
- Ubiquitin and proteasome pathways 5
- Co-authors
- Kathryn Packman (22 shared papers)Brian Higgins (18 shared papers)David Heimbrook (17 shared papers)Christian Tovar (9 shared papers)Zoran Filipovic (4 shared papers)Binh Thanh Vu (3 shared papers)James Rosinski (1 shared paper)Ola Myklebost (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (5 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandNew Zealand
In The Last Decade
Kenneth Kolinsky
33 papers receiving 2.2k citations
Kenneth Kolinsky's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 1.3k
- Cancer Research 294
- Molecular Biology 1.3k
- Immunology 326
- Biotechnology 123
Countries citing papers authored by Kenneth Kolinsky
This map shows the geographic impact of Kenneth Kolinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Kolinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Kolinsky more than expected).
Fields of papers citing papers by Kenneth Kolinsky
This network shows the impact of papers produced by Kenneth Kolinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Kolinsky. The network helps show where Kenneth Kolinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth Kolinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 553 |
| 2 | 2010 | 307 | |
| 3 | 1991 | 254 | |
| 4 | 2013 | 220 | |
| 5 | 2011 | 170 | |
| 6 | 2004 | 126 | |
| 7 | 1996 | 118 | |
| 8 | 2006 | 88 | |
| 9 | 2014 | 50 | |
| 10 | 2006 | 42 | |
| 11 | 2011 | 38 | |
| 12 | 2011 | 36 | |
| 13 | 2009 | 34 | |
| 14 | 2010 | 27 | |
| 15 | 2009 | 25 | |
| 16 | 2010 | 24 | |
| 17 | 2010 | 23 | |
| 18 | 2006 | 21 | |
| 19 | Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model. | 2007 | 21 |
| 20 | 2005 | 17 |
About Kenneth Kolinsky
Kenneth Kolinsky is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Organic Chemistry and Cancer Research, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Cancer Treatment and Pharmacology (7 papers), Melanoma and MAPK Pathways (7 papers), HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (294 citations), Molecular Biology (1.3k citations), Immunology (326 citations) and Biotechnology (123 citations). Kenneth Kolinsky has collaborated with scholars based in United States, Switzerland and New Zealand. Frequent co-authors include Kathryn Packman, Brian Higgins, David Heimbrook, Christian Tovar, Zoran Filipovic, Binh Thanh Vu, James Rosinski, Ola Myklebost, Lyubomir T. Vassilev and Xiaolan Zhao. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.